Relacorilant, an oral treatment being developed by Corcept Therapeutics, appears to be safe and effective for controlling high blood pressure caused by hypercortisolism, or excess cortisol, in adults with endogenous Cushing’s syndrome, including Cushing’s disease. That’s according to GRACE (NCT03697109), an international Phase 3 clinical study…